Myositis Treatment in India: Costs, Specialists and Where to Start
Explore myositis treatment in India with insights on costs, leading specialists, and guidance on how to start your path to recovery effectively.

A diagnosis of myositis can leave patients with two immediate questions: Who should treat this disease, and how much will treatment cost? In India, both questions can be difficult to answer because myositis is rare and treatment varies considerably from one patient to another.
There is no single fixed cost for myositis treatment in India. The total expense depends on the type and severity of disease, investigations required, medicines prescribed, hospitalisation, rehabilitation and whether advanced treatments such as IVIG are needed.
Who treats myositis in India?
A rheumatologist is often central to the care of adults with autoimmune inflammatory myopathies. Depending on the symptoms, a neurologist, dermatologist, pulmonologist, physiotherapist or other specialist may also be involved.
For example, a patient with significant muscle weakness may benefit from neurological or neuromuscular assessment, particularly when the diagnosis or pattern of weakness is unclear.Breathing difficulties can require assessment for lung involvement, and swallowing problems may need specialised evaluation.
Because myositis can affect more than muscles, multidisciplinary care can be particularly useful. Myositis India maintains an expert network that allows patients to search for specialists by location and speciality.
What does myositis treatment cost?
It is difficult to give one meaningful figure for myositis treatment in India. Basic consultations, blood tests and commonly prescribed medicines may represent a very different expense from prolonged hospital care or advanced therapies.
The cost of IVIG can be particularly significant. Published medical literature has described its high cost as one of the major limitations to its use in India.
The financial burden can also come from repeated investigations, specialist consultations, physiotherapy and travel to centres with experience in rare autoimmune diseases. For this reason, patients should ask the treating hospital for an estimate based on the proposed treatment plan rather than relying on a general figure found online.
What investigations may add to the cost?
Myositis diagnosis may involve several tests rather than one definitive test. Depending on the presentation, doctors may request muscle enzymes such as creatine kinase, autoantibody testing, MRI, electromyography, muscle or skin biopsy and assessments for organ involvement.
Not every patient requires every investigation. The doctor decides what is appropriate based on the symptoms and clinical findings. This is another reason why treatment costs can vary significantly between patients.
Can government support help with rare disease expenses?
India has a National Policy for Rare Diseases and a government portal that facilitates crowdfunding and voluntary donations for eligible patients with rare diseases. However, government support is subject to the policy's eligibility criteria, disease categories and implementation arrangements, and it should not be assumed that every person with myositis will automatically qualify for financial assistance.
Patients should ask their treating institution whether any applicable government scheme, hospital assistance programme or other financial support is available.
Where should a newly diagnosed patient start?
The first priority should be finding a doctor experienced in managing inflammatory myopathies. Carrying previous blood reports, scans, biopsy reports, prescriptions and a brief timeline of symptoms can make the first specialist consultation more useful.
It is also worth asking practical questions. What type of myositis is suspected? Which organs need monitoring? What is the purpose of each medicine? How long might treatment continue? What side effects should be reported? Is physiotherapy appropriate? What warning signs require urgent medical attention?
Patients should also be cautious about stopping prescribed medicines, replacing treatment with unverified remedies or spending large amounts on treatments advertised as cures. Myositis treatment needs to be based on the individual's diagnosis and medical assessment.
Where does Myositis India fit into the journey?
For patients and families who do not know where to begin, Myositis India provides a support network rather than functioning as a hospital or clinic. The organisation connects patients and caregivers with information, specialist networks, support sessions, clinical research opportunities and the wider myositis community.
This kind of support can matter greatly in a rare disease. Myositis India also works towards greater awareness, research and access to appropriate care across the country. Patients can use its support services to better understand their options and find the right questions to take to their treating team.
FAQs
1. Which doctor should a person with myositis see in India?
A rheumatologist is often an important specialist for autoimmune inflammatory myopathies. Depending on symptoms, neurologists, dermatologists, pulmonologists and rehabilitation specialists may also be involved.
2. Is myositis treatment expensive in India?
Costs vary widely. Medicines, tests, specialist consultations, physiotherapy and hospitalisation can all contribute to expenses. Advanced treatments such as IVIG can be particularly costly.
3. Does every patient need IVIG?
No. IVIG is generally considered for selected patients, including some with severe or refractory disease. The decision should be made by the treating specialist.
4. Can a patient get help finding a myositis specialist?
Myositis India provides an expert network where patients can search for rheumatologists and other specialists by location and speciality.
5. Does Myositis India provide medical treatment?
No. Myositis India is a non-profit patient advocacy and support organisation, not a hospital or clinic. It helps patients connect with medical professionals and access reliable information and support.
